Table 2.
White matter injury (N = 6) |
No white matter injury (N = 23) |
|
---|---|---|
| ||
Age (Mean ±SD) | 14.8 ± 2.8 | 14.3 ± 2.9 |
| ||
Male Sex (%) | 4 (66%) | 13 (57%) |
| ||
CKD Stage (including transplant) | ||
Stage 2 | 1 | 7 |
Stage 3 | 2 | 8 |
Stage 4 | 1 | 3 |
Stage 5 | 2 | 5* |
| ||
Duration of CKD (months), median | 62 (12, 120) | 97 (57, 158) |
(IQR) | ||
| ||
Hypertension (%) | 2 (33) | 15 (65) |
| ||
Hemoglobin, g/L (±SD) | 124.7 ± 19.4 | 125.4 ± 14.0 |
Staging of CKD was based on the GFR categories outlined in the KDIGO 2012 clinical practice guideline for the evaluation and management of CKD, combining stage 3a and 3b [33].
2/5 were on peritoneal dialysis